Fasting during chemo: a new way to ease side effects?
NCT ID NCT06645093
First seen Mar 27, 2026 · Last updated Jun 23, 2026 · Updated 17 times
Summary
This study looks at whether fasting for 24 hours before and after chemotherapy is safe and doable for people with Hodgkin or Diffuse Large B Cell Lymphoma. 40 participants will either fast or follow standard care, tracking side effects, diet, and quality of life. The goal is to see if a larger trial is possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Nutrition, University of Oslo
Oslo, Oslo, 0372, Norway
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Fasting (water-only for 24 hours before and after chemotherapy)
What this could lead to
If it works, this could show that fasting is a safe and tolerable way to potentially reduce side effects during lymphoma chemotherapy.
What could go wrong
This is a very small feasibility trial with only 40 people, so results may not apply broadly. Fasting may be hard to stick with and could cause weight loss or other issues.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.